Stroke, Vol 8, 672-675, Copyright © 1977 by American Heart Association
AA Hagen, JN Gerber, CC Sweeley, RP White and JT Robertson
The concentration of prostaglandin F2alpha (PGF2alpha) was measured in
cerebrospinal fluid (CSF) obtained by lumbar puncture in patients with
subarachnoid hemorrhage and compared to control values. The level of this
prostaglandin was elevated at some time in most patients during the course
of their illness. However, this could not be correlated with the severity
of neurological deficits observed. The possibility that the concentration
of PGF2alpha in lumbar fluid may not reflect that present intracranially
was tested experimentally in anesthetized dogs. In these experiments only a
small fraction of the radioactive PGF2alpha injected into the cisterna
magna appeared in lumbar CSF. Prostaglandin F2alpha rapidly disappeared
from the cisterna magna, half time 8 minutes, and radioactivity was present
in blood from the jugular vein indicating that normally this prostaglandin
rapidly egresses from the CSF into blood. These findings suggest that
PGF2alpha can be rapidly transported away from the brain. This could
explain the low concentrations of PGF2alpha in CSF of normal individuals
and in some patients who have severe cerebral vasospasm. Conversely, the
elevation of PGF2alpha in lumbar CSF noted in some patients might be due,
in part, to an impairment of transport caused by the size and location of
the hemorrhage.
ARTICLES
Levels and disappearance of prostaglandin F2alpha in cerebral spinal fluid: a clinical and experimental study
This article has been cited by other articles:
![]() |
J. N. Topper, J. Cai, G. Stavrakis, K. R. Anderson, E. A. Woolf, B. A. Sampson, F. J. Schoen, D. Falb, and M. A. Gimbrone Jr Human Prostaglandin Transporter Gene (hPGT) is Regulated by Fluid Mechanical Stimuli in Cultured Endothelial Cells and Expressed in Vascular Endothelium in Vivo Circulation, December 1, 1998; 98(22): 2396 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malmberg and T. Yaksh Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition Science, August 28, 1992; 257(5074): 1276 - 1279. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1977 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |